You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Her2neu positive breast cancer.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Breast Cancer Trial in New York (Docetaxel, Carboplatin, Trastuzumab)

Terminated
  • Locally Advanced Breast Cancer
  • New York, New York
  • +2 more
Oct 18, 2021

Tumor Metastasis Trial in New York (Intra-arterial Cerebral Infusion of Trastuzumab)

Terminated
  • Neoplasm Metastasis
  • Intra-arterial Cerebral Infusion of Trastuzumab
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Breast Cancer, HER2-positive Trial in Houston (Zanidatamab, Letrozole, Tamoxifen)

Recruiting
  • Breast Cancer
  • HER2-positive
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

Active, not recruiting
  • Estrogen Receptor Positive
  • +3 more
  • Radiation Therapy
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 14, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Carcinoma Breast Stage I, HER2 Positive Breast Cancer Trial in Mumbai (Trastuzumab, Placebo)

Recruiting
  • Carcinoma Breast Stage I
  • HER2 Positive Breast Cancer
  • Mumbai, India
    Tata Memorial Centre
Apr 26, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Norfolk, Omaha (drug,

Active, not recruiting
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Norfolk, Nebraska
  • +2 more
Sep 1, 2021

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Active, not recruiting
Has Results
  • Anatomic Stage II Breast Cancer AJCC v8
  • +16 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Breast Cancer Trial in United States (Placebo, GLSI-100)

Recruiting
  • Breast Cancer
  • Placebo
  • GLSI-100
  • Birmingham, Alabama
  • +21 more
Jan 30, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Breast Cancer Trial in Omaha (Palbociclib 125mg)

Recruiting
  • Breast Cancer
  • Palbociclib 125mg
  • Omaha, Nebraska
    Nebraska Medicine
Mar 3, 2022

HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker

Active, not recruiting
  • HER2/Neu Negative
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
  • +1 more
Jan 11, 2022

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting
Has Results
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
Jun 8, 2022

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Active, not recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +21 more
  • Ipilimumab
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,

Active, not recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Atlanta, Georgia
  • +9 more
Oct 12, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +6 more
  • Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +8 more
Feb 3, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +13 more
  • Bintrafusp Alfa
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2021

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 31, 2022

Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,

Terminated
Has Results
  • Stage III Breast Cancer
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 10, 2021

Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (External Beam Radiation

Recruiting
  • Estrogen Receptor Negative
  • +11 more
  • External Beam Radiation Therapy
  • +4 more
  • Phoenix, Arizona
  • +7 more
Aug 4, 2021